Healthcare spending in America has remained a prominent topic of debate, with much concern over the rising list prices and out-of-pocket costs for patients seeking prescription drugs. Associated with these increasing costs is the industry practice of using rebates to lower drug costs for insurers. A University of Washington-led study examined cost and price data on more than 400 branded drugs. The researchers uncovered a positive association between rebates and increases in out-of-pocket costs for patients. Prices increased by an…
Researchers have established a link between drug rebates and higher costs to patients









